Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Phase III Study to Determine the Safety, Efficacy, and Immunogenicity of the Non-Replicating ChAdOx1 nCoV-19 Vaccine

NCT04536051 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT04536051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04536051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Phase III Study to Determine the Safety, Efficacy, and Immunogenicity of the Non-Replicating ChAdOx1 nCoV-19 Vaccine
Lead sponsor
University of Oxford
Phase
Phase 3
Overall status
Unknown status
Start date
June 2, 2020
Completion date
September 30, 2021
Enrollment
10,300 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus